Evidence map›Paper›PMID 37556453›Full record

ArticlePloS one2023

A sub-chronic feeding study of dual toxin insect-resistant transgenic maize (CEMB-413) on Wistar rats.

Ayesha Liaqat, Ibrahim Bala Salisu, Allah Bakhsh, Qasim Ali, Ayesha Imran, Muhammad Azam Ali, Abdul Munim Farooq, Abdul Qayyum Rao, Ahmad Ali Shahid

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ayesha LiaqatCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Ibrahim Bala SalisuCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Allah BakhshCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.ORCID 0000-0003-3561-7863
Qasim AliCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Ayesha ImranCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Muhammad Azam AliCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Abdul Munim FarooqCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Abdul Qayyum RaoCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Ahmad Ali ShahidCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetically modified (GM) crops expressing insecticidal crystal proteins are widely accepted worldwide, but their commercial utilization demands comprehensive risk assessment studies. A 90-day risk assessment study was conducted on Wistar rats fed with GM maize (CEMB-413) expressing binary insect-resistant genes (cry1Ac and cry2Ab) at low (30%) and high (50%) dose along with a control diet group. The study used fifty Wistar rats randomly distributed in five treatment groups. Our study revealed that compared to controls, GM diet had no adverse effects on animal's health, including body weight, food consumption, clinical pathological parameters, serum hormone levels and histological parameters of testes and ovaries of rats. Differences were observed in transcripts levels of fertility related genes, but these were independent of treatment with GM diet.

Indexed as

Bacterial ProteinsZea maysAnimalsAnimals, Genetically ModifiedEndotoxinsHemolysin ProteinsInsectaPlants, Genetically ModifiedRatsRats, WistarBacterial ProteinsEndotoxinsHemolysin Proteins

Identifiers

PMID37556453
PMCPMC10411795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.